Patents Assigned to Azurebio, S.L.
  • Patent number: 9271927
    Abstract: The invention relates to percutaneous administration of drugs and vaccines in form of solid penetrating needles, “injectable needles”, comprising a polymeric matrix resulting from the polymerization of a polymerizable paste or mixture. The injectable needles are hard enough to penetrate the skin and can be administered percutaneously by simple pusher or injector delivery devices. The manufacturing procedure of the injectable needles allows for the incorporation of the drug as preformulated stable microparticles and incorporation of modifying agents to modulate stiffness, solubility and drug release. Drugs formulated in these injectable needles offer a safe, simple and effective alternative to conventional percutaneous drug delivery systems based on hypodermic needles and syringes that require refrigerated storage and reconstitution prior to administration.
    Type: Grant
    Filed: October 8, 2010
    Date of Patent: March 1, 2016
    Assignee: AZUREBIO, S.L.
    Inventors: Arcadio García De Castro Andrews, Raúl García Carrodeaguas, Niuris Acosta Contreras
  • Patent number: 8506985
    Abstract: The present invention incorporates new materials for bone regeneration, methods for their manufacture, and application in traumatology surgery, maxillofacial surgery, dental surgery, orthognatic surgery, endodontics, ophthalmology, neurosurgery and/or osteoporotic processes, and other indications where bone regeneration is required. In particular, the present invention incorporates synthetic materials with a 20% to a 95%, preferably between 40% and 90% in mass of monetite [Ca1-XMXHPO4, where 0?x?0.05, and where M can be a divalent metallic ion], and which in their final composition incorporate between 5% and 80%, preferably between 0% and 60%, in mass of bioactive calcium compounds chosen from calcium phosphates and between 5% and 80% in total mass of bioactive silicon compounds chosen from calcium silicates and/or bioactive silica glasses and gels.
    Type: Grant
    Filed: February 4, 2010
    Date of Patent: August 13, 2013
    Assignee: Azurebio, S.L.
    Inventors: Arcadio Garcia De Castro Andrews, Raul Garcia Carrodeguas, Sussette Padilla Mondéjar, Niuris Acosta Contreras
  • Patent number: 8465448
    Abstract: The present disclosure refers to hand operated disposable devices for the administration of drugs, vaccines and other medicaments in the form of solid injectable needles. The devices incorporate mechanisms for the automatic retraction of the injection rod even when the user continues to exert pressure on the device. The devices can incorporate an injectable needle in a sheath or cartridge that facilitates its manufacture and manipulation. These injection devices can only be used once and their use results in a change of configuration that renders them non operational and prevents contact with parts that have been exposed to the patient's tissues.
    Type: Grant
    Filed: February 18, 2009
    Date of Patent: June 18, 2013
    Assignee: Azurebio S.L.
    Inventor: Arcadio Garcia De Castro Andrews
  • Publication number: 20120219589
    Abstract: The invention relates to percutaneous administration of drugs and vaccines in form of solid penetrating needles, “injectable needles”, comprising a polymeric matrix resulting from the polymerization of a polymerizable paste or mixture. The injectable needles are hard enough to penetrate the skin and can be administered percutaneously by simple pusher or injector delivery devices. The manufacturing procedure of the injectable needles allows for the incorporation of the drug as preformulated stable microparticles and incorporation of modifying agents to modulate stiffness, solubility and drug release. Drugs formulated in these injectable needles offer a safe, simple and effective alternative to conventional percutaneous drug delivery systems based on hypodermic needles and syringes that require refrigerated storage and reconstitution prior to administration.
    Type: Application
    Filed: October 8, 2010
    Publication date: August 30, 2012
    Applicant: AZUREBIO ,S.L.
    Inventors: Arcadio García De Castro Andrews, Raúl García Carrodeaguas, Niuris Acosta Contreras
  • Publication number: 20120058152
    Abstract: The present invention incorporates new materials for bone regeneration, methods for their manufacture, and application in traumatology surgery, maxillo facial surgery, dental surgery, orthognatic surgery, endodontics, ophthalmology, neurosurgery and/or osteoporotic processes, and other indications where bone regeneration is required. In particular, the present invention incorporates synthetic materials with a 20% to a 95%, preferably between 40% and 90% in mass of monetite [Ca1-XMXHPO4, where 0?x?0.05, and where M can be a divalent metallic ion], and which in their final composition incorporate between 5% and 80%, preferably between 0% and 60%, in mass of bioactive calcium compounds chosen from calcium phosphates and between 5% and 80% in total mass of bioactive silicon compounds chosen from calcium silicates and/or bioactive silica glasses and gels.
    Type: Application
    Filed: February 4, 2010
    Publication date: March 8, 2012
    Applicant: Azurebio, S.L.
    Inventors: Arcadio Garcia de Castro Andrews, Raul Garcia Carrodeguas, Sussette Padilla Mondéjar, Niuris Acosta Contreras